Sodium cyanate alters glutathione homeostasis in rodent brain: Relationship to neurodegenerative diseases in protein-deficient malnourished populations in Africa

Brain Research

Volumn 820, Issue 1-2, 1999, Pages 12-19

  Tor Agbidye, John ^a   Palmer, Valerie S ^b   Spencer, Peter S ^a   Craig, A Morrie ^c   Blythe, Linda L ^c   Sabri, Mohammad I ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Third World Med Research Foundation   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Glutathione homeostasis; Glutathione peroxidase; Glutathione reductase; GSH; GSSG; Neurodegenerative disease; Neurotoxicity; Sodium cyanate

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MESSENGER RNA; SODIUM CYANATE;

AFRICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CASSAVA; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HIPPOCAMPUS; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; LIVER; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RAT;

AFRICA; ANIMALS; BRAIN; CYANATES; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; HOMEOSTASIS; HUMANS; LIVER; MICE; MICE, INBRED STRAINS; NERVE DEGENERATION; NUTRITION DISORDERS; PROTEIN DEFICIENCY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0033608458     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01343-2     Document Type: Article

References (44)

1. Alter B.P., Kan Y.W., Nathan D.G. The toxic effects of high-dose cyanate administration in rodents. Blood. 43:1974;69-77.
2. Anderson P.M. Purification and properties of the inducible enzyme cyanase. Biochemistry. 19:1980;2882-2888.
3. Cammer W. Release of mitochondrial respiratory control by cyanate salts. Biochim. Biophys. Acta. 679:1982;343-346.
4. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol. 113:1985;484-490.
5. Cerami A., Allen A.T., Graziano J.H., Defuria F.G., Manning J.M., Gillente P.N. Pharmacology of cyanate: 1. General effects on experimental animals. J. Pharmacol. Exp. Ther. 185:1973;653-666.
6. Cliff J., Lundquist P., Martenson J., Rosling H., Sorbo B. Association of high cyanide and low sulfur intake in cassava-induced spastic paraparesis. Lancet. II:1985;1211-1213.
7. Coles B. Effects of modifying structure on electrophilic reactions with biological nucleophiles. Drug Metab. Rev. 15:1985;1307-1334.
8. Commandeur J.N.M., Gerard J.S., Vermeulen N.P.E. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates: role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol. Rev. 47:1995;271-330.
9. Crist R.D., Grisolia S., Bettis C.J., Grisolia J. Carbamoylation of proteins following administration to rats of carbamoyl phosphate and cyanate and effects on memory. Eur. J. Biochem. 32:1973;109-116.
10. DeLeve L.D., Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol. Ther. 52:1991;287-305.
11. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:1959;70-77.
12. F. Esclair, G. Kisby, P.S. Spencer, J. Milne, M. Lesort, H. Hugon, The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau expression and excitotoxicity. Exp. Neurol. (in press).
13. Folbergrova J., Rehncrona S., Siesjo B. Oxidized and reduced glutathione in the rat brain under normoxic and hypoxic conditions. J. Neurochem. 32:1979;1621-1627.
14. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. J. Neurochem. 13:1966;655-669.
15. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced gluthione in tissues. Anal. Biochem. 74:1976;214-226.
16. Howlett W.P., Brubaker G.R., Mlingi N., Rosling H. Konzo, an epidemic upper motor neuron disease studied in Tanzania. Brain. 113:1990;223-235.
17. Hwang C., Sinskey A.J., Lodish H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 257:1992;1496-1502.
18. Jain A., Madsen D.C., Auld P.A., Frayer W.W., Schwartz M.K., Meister A., Martensson J. L-2-Oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet. J. Nutr. 125:1995;851-856.
19. Lomaestro B.M., Malone M. Glutathione in health and disease: pharmacotherapeutic issues. Ann. Pharmacother. 29:1995;1263-1273.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
21. Martensson J., Lai J.C.K., Meister A. High-affinity transport of glutathione is part of a multicomponent system essential for mitochondrial function. Proc. Natl. Acad. Sci. USA. 87:1990;7185-7189.
22. Meister A. Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta. 1271:1995;35-42.
23. Moldeus P., Quanguan J. Importance of the glutathione cycle in drug metabolism. Pharmacol. Ther. 33:1987;37-40.
24. Ohnishi A., Peterson C.M., Dyck P.J. Axonal degeneration in sodium cyanate-induced neuropathy. Arch. Neurol. 32:1975;530-534.
25. Orlowski M., Karkowsky A. Glutathione metabolism and some possible functions of glutathione in the nervous system. Int. Rev. Neurobiol. 19:1976;75-121.
26. Osuntokun B.O. Cassava diet, chronic cyanide intoxication and neuropathy in Nigerian Africans. World Rev. Nutr. Diet. 36:1981;141-173.
27. Peterson C.M., Tsairis P., Ohnishi A., Lu Y.S., Grady R., Cerami A., Dyck P.J. Sodium cyanate-induced polyneuropathy in patients with sickle-cell disease. Ann. Int. Med. 81:1974;152-158.
28. H. Rosling, Molecular anthropology of cassava cyanogenesis, in: B.W.S. Soral (Ed.), The Impact of Plant Molecular Genetics, Birkenhauser, Boston, MA, 1996, pp. 315-327.
29. Rybak L.P., Ravi R., Somani S.M. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam. Appl. Toxicol. 26:1995;293-300.
30. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:1994;348-355.
31. Sabri M.I., Tor-Agbidye J., Palmer V.S., Spencer P.S. Glutathione and glutathione reductase activity are reduced in rodent brain by cyanate. J. Neurochem. 66:1996;S14C.
32. Samson F.E., Hinkley R.E. Jr. Neuronal microtubular systems. Anesthesiology. 36:1972;417-421.
33. Shaw C.-M., Papayannopoulou T., Stamatoyannopoulos G. Neuropathology of cyanate toxicity in rhesus monkeys. Pharmacology. 12:1974;166-176.
34. Shivakumar B.R., Ravindranath V. Selective modulation of glutathione in mouse brain regions and its effects on acrylamide-induced neurotoxicity. Biochem. Pharmacol. 43:1992;263-269.
35. Smith C.V., Jones D.P., Guenthner T.M., Lash L.H., Lauterburg B.H. Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol. Appl. Pharmacol. 140:1996;1-12.
36. Srivastava S.K., Beutler E. Accurate measurement of oxidized glutathione content of human, rabbit and rat red blood cells and tissues. Anal. Biochem. 25:1968;70-76.
37. 2-terminal residues in protein. J. Biol. Chem. 238:1963;214-226.
38. Tellez I., Johnson D., Nagel R.L., Cerami A. Neurotoxicity of sodium cyanate: new pathological and ultrastructural observations in Macaca nemestrina. Acta Neuropathol. 47:1979;75-79.
39. Toborek M., Hennig B. Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am. J. Clin. Nutr. 59:1994;60-65.
40. Tor-Agbidye J., Agoston T., Lystrup B., Sabri M.I., Spencer P.S. Selective inhibition of brain mitochondrial cytochrome c oxidase (complex IV) by sodium cyanate. J. Neurochem. 64:1995;S96C.
41. Tor-Agbidye J., Palmer V.S., Agoston T., Lystrup B., Sabri M.I., Spencer P.S. Sodium cyanate reduces rat brain glutathione reductase activity. Fund. Appl. Toxicol. 30:1996;283.
42. J. Tor-Agbidye, Cyanide Metabolism in Sulfur Amino Acid Deficiency: Relevance to Cassava-related Human Neurodegenerative Diseases, PhD Dissertation, Oregon State University, Corvallis, OR, 1997.
43. Tylleskär T., Banea M., Bikangi N., Cooke R., Poulter N., Rosling H. Cassava cyanogens and Konzo, an upper motor neuron disease found in Africa. Lancet. 339:1992;208-211.
44. T. Tylleskär, The Causation of Konzo: Studies on a Paralytic Disease in Africa, PhD Dissertation, Uppsala University, Sweden, 1994.